Understanding how BRWD1 influences B cell development and immune response
The role of BRWD1 to establish epigenetic states for germinal center initiation, maintenance, and exit
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF CHICAGO · NIH-11014965
This study is looking at a protein called BRWD1 to see how it helps B cells, which are important for our immune system, grow and work properly, and the findings could help us understand better how B cells behave in autoimmune diseases and other immune-related issues.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-11014965 on ClinicalTrials.gov |
What this research studies
This research investigates the role of a protein called BRWD1 in the development and function of B cells, which are crucial for the immune system. By studying genetically modified mice, the researchers aim to understand how BRWD1 affects the ability of B cells to form germinal centers, where they mature and produce antibodies. The study focuses on the different subpopulations of B cells and how their epigenetic states influence their function and differentiation. Patients may benefit from insights gained about B cell responses in autoimmune diseases and other conditions related to immune function.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with autoimmune disorders or those with compromised immune responses.
Not a fit: Patients with conditions unrelated to B cell function or those not experiencing immune system issues may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing immune responses or treating autoimmune diseases by targeting B cell differentiation.
How similar studies have performed: Other research has shown promising results in understanding B cell differentiation and function, suggesting that this approach could yield valuable insights.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WRIGHT, NATHANIEL EDWIN — UNIVERSITY OF CHICAGO
- Study coordinator: WRIGHT, NATHANIEL EDWIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.